No Result

View All Result

No products in the cart.

Home Tag B-cell lymphoma

Tag: B-cell lymphoma

$#VisualAbstract Obesity and body weight was not correlated with survival outcomes in patients with relapsed/refractory large B-cell lymphoma treated with CAR T-Cell therapy$

#VisualAbstract Obesity and body weight was not correlated with survival outcomes in patients with relapsed/refractory large B-cell lymphoma treated with CAR T-Cell therapy

byKathleen Lau

July 11, 2021

#VisualAbstract: Topical calcineurin inhibitor use is associated with an increased risk of lymphoma

byTeddy Guo

May 26, 2021

Click to read the study in JAMA Dermatology.

$#VisualAbstract Phase 1 trial shows loncastuximab tesirine demonstrated significant response rates and an acceptable safety profile in patients with relapsed/refractory B-cell non-Hodgkin lymphoma$

#VisualAbstract Phase 1 trial shows loncastuximab tesirine demonstrated significant response rates and an acceptable safety profile in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

byKathleen Lau

May 21, 2021

#VisualAbstract Rituximab plus high-dose chemotherapy (MegaCHOEP) show similar long-term efficacy to conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma

byKathleen Lau

April 9, 2021

Combined lenalidomide and rituximab dose escalation found to be safe for CLL

Pirtobrutinib is safe and efficacious in the treatment of relapsed or refractory B-cell malignancies (BRUIN Trial)

byMichael Pratteand1 others

March 18, 2021

1. Bruton’s tyrosine kinase inhibitor pirtobrutinib showed efficacy in the treatment of relapsed or refractory B-cell malignancies such as chronic ...

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

byKathleen Lau

January 8, 2021

#VisualAbstract Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

byKathleen Lau

January 7, 2021

#VisualAbstract PET Scan Adapted Approach in Primary Mediastinal Large B-Cell Lymphoma (PMBCL) using R-CHOP

byKathleen Lau

December 17, 2020

$#VisualAbstract CONTRALTO Phase II: Venetoclax-Rituximab With or Without Bendamustine VS Bendamustine-Rituximab in Relapsed/Refractory Follicular Lymphoma$

#VisualAbstract CONTRALTO Phase II: Venetoclax-Rituximab With or Without Bendamustine VS Bendamustine-Rituximab in Relapsed/Refractory Follicular Lymphoma

byKathleen Lau

December 11, 2020

#VisualAbstract B-Cell Targeted Therapies in CANOMAD Syndrome

byKathleen Lau

December 4, 2020

Page 2 of 3 Prev 1 2 3 Next

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result